Sucanon Middle East clinical trials in final stage: Fero Industries
Sucanon is one of only three approved drugs for a class of diabetic medications called ‘Insulin Sensitizers’ in the multi-billion dollar market. It lowers a patient’s blood sugar
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.
NICE’s evaluation took into account peer-reviewed clinical studies that demonstrated VIDAZA as an innovative epigenetic, life-extending, cost-effective therapy for the National Health Service (NHS). Celgene Corporation CEO Robert